hA20

Humanized anti-CD20 · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hA20, covering 2021-08-17 to 2021-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma [Phase 1, Phase 2]